Notable Downgrades: PTC Therapeutics (PTCT), Seagate (STX), Spirit Airlines (SAVE), Citigroup (C)

Analysts at Oppenheimer lowered their PTC Therapeutics, Inc. (PTCT) target to $56 from $85 in a research report issued to clients on Friday. The firm notes company’s confirmatory Phase III trial in DMD failed to meet its primary or secondary endpoints. PTCT was also lowered to $135 from $155 at Oppenheimer. Shares of the $1.12 […] View the full post at: Notable Downgrades: PTC Therapeutics (PTCT), Seagate (STX), Spirit Airlines (SAVE), Citigroup (C) Related posts: Spirit Airlines Combats the Tragedy of the Overhead Bin Top Pre-Market Stock Upgrades/Downgrades March 22, 2010 Top Pre-Market Stock Upgrades/Downgrades April 23, 2010